CIC GOOD CLINICAL PRACTICE (GCP) WORKSHOP POSTPONEMENT
Greetings from CIC! Following the current pandemic situation and MCO status in Malaysia, all face-to-face workshops must be postponed until further notice. We are looking
Greetings from CIC! Following the current pandemic situation and MCO status in Malaysia, all face-to-face workshops must be postponed until further notice. We are looking
As announced by the Ministry of Health (MOH), there is an additional one (1) clinical trial study involving the COVID-19 vaccine that has been approved
COVID-19 INFORMATION: MOVEMENT CONTROL ORDERS (MCO) 3.0 The Malaysian government has announced Movement Control Order (MCO) 3.0 from 25th May 2021 until 7th June 2021.
Factsheet written by Dr Phan Chia Wei, Head of CIC, on clinical trials on COVID-19 worldwide. The factsheet is published by the Academy of Science
Malaysia is embarking on a clinical study to evaluate the drug Tocilizumab for the treatment of severe cases of Covid-19. Led by Universiti Malaya Faculty
Great news and new hope! CIC and the UMMC Covid-19 special taskforce go full force looking for new treatment for Covid-19 patients. “UMMC has already
© CIC. All Rights Reserved. 2024